Brief: Ensysce Biosciences Announces Successful Meeting with FDA For PF614-MPAR, A Next Generation Opioid With Overdose Protection
21/02/2024 15:04
Feb 21 (Reuters) - Ensysce Biosciences Inc ENSC.O :
* ENSYSCE BIOSCIENCES INC- SUCCESSFUL MEETING WITH FDA FOR
PF614-MPAR, A NEXT GENERATION OPIOID WITH OVERDOSE PROTECTION
Further company coverage: ENSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ensysce Biosciences
See all newsEnsysce Biosciences Q2 net loss widens on higher R&D costs
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing